← Evidence map

ArticleDermatology and therapy2025

Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling.

Beverly Knight et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40629250